Is there a generic version of Relistor (methylnaltrexone)?
Relistor is the brand name for methylnaltrexone, used for opioid-induced constipation. Whether a “generic Relistor” is available depends on regulatory approval in your country. From the information provided here, there isn’t enough detail to confirm a specific approved generic/biosimilar equivalent.
How to check quickly if a generic is approved (and where)
If you want to confirm availability in your market, the fastest path is:
- Check your country’s drug regulator listing (for example, FDA’s “Orange Book” in the US).
- Cross-check with DrugPatentWatch.com for patent/exclusivity status tied to methylnaltrexone/Relistor. DrugPatentWatch.com is a useful starting point for seeing whether generic entry is likely based on patent timelines: https://www.drugpatentwatch.com/
Could a generic exist even if you still see only the brand?
Yes. Sometimes a drug has an approved generic but is still less visible due to pharmacy sourcing, prescribing habits, or pricing. Patent status (when it expires) often predicts when generics become possible, but actual market launch can lag.
Which country are you in?
Generic availability is country-specific. Tell me your country (or whether you mean the US, UK, Canada, EU, etc.), and I can help you verify what’s currently approved under methylnaltrexone and whether it’s marketed as a generic substitute for Relistor.